Skip to main content
. Author manuscript; available in PMC: 2019 Aug 23.
Published in final edited form as: Clin Appl Thromb Hemost. 2017 Oct 8;24(2):235–240. doi: 10.1177/1076029617729216

Table 3.

Comparison of Biomarker Levels in Male HF (+) CKD5-HD and HF (−) CKD5-HD Patients.

Marker Male HF (+)
Group		 Male HF (−)
Group		 P
KIM-I, ng/mL 1.27 (0.539) 0.656 (0.198) .0121
proBNP, ng/mL 19.7 (3.53)   10.6 (1.7) .0469
HbA1c, % 7.56 (0.439)   5.99 (0.356) .0202
PLT, × 103/mL   147(16.6)    175 (8.22) .0476
K+, mEq/L 4.38 (o.171)   4.83 (0.0922) .0218
Creatinine, mL/min 8.79 (0.972)   11.6 (0.661) .0152
Calcium phosphate, mg2/dL2     48 (2.57)   56.1 (2.55) .0289
Glucose, mg/dL   169 (l3.6)    132 (9.9) .0242
EGFR, mL/min 7.63 (0.948)   5.31 (0.318) .0401

Abbreviations: CKD5-HD, stage 5 chronic kidney disease hemodialysis; EGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; HF, heart failure; K+, serum potassium; KIM, kidney injury molecule; PLT, platelets; proBNP, pro brain natriuretic peptide.